Here is the original study that inspired our interest in Carbon 60 Olive Oil:

Tarek Baati, Fanchon Bourasset, Najla Gharbi, Leila Njim, Manef Abderrabba, Abdelhamid Kerkeni, Henri Szwarc, Fathi Moussa, The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene, Biomaterials, Volume 33, Issue 19, June 2012, Pages 4936-4946, ISSN 0142-9612, 10.1016/j.biomaterials.2012.03.036. (

Abstract: Countless studies showed that [60]fullerene (C60) and derivatives could have many potential biomedical applications. However, while several independent research groups showed that C60 has no acute or sub-acute toxicity in various experimental models, more than 25 years after its discovery the in vivo fate and the chronic effects of this fullerene remain unknown. If the potential of C60 and derivatives in the biomedical field have to be fulfilled these issues must be addressed. Here we show that oral administration of C60 dissolved in olive oil (0.8 mg/ml) at reiterated doses (1.7 mg/kg of body weight) to rats not only does not entail chronic toxicity but it almost doubles their lifespan. The effects of C60-olive oil solutions in an experimental model of CCl4 intoxication in rat strongly suggest that the effect on lifespan is mainly due to the attenuation of age-associated increases in oxidative stress. Pharmacokinetic studies show that dissolved C60 is absorbed by the gastro-intestinal tract and eliminated in a few tens of hours. These results of importance in the fields of medicine and toxicology should open the way for the many possible -and waited for- biomedical applications of C60 including cancer therapy, neurodegenerative disorders, and ageing. Keywords: Fullerenes; Toxicity; Pharmacokinetics; Ageing; Oxidative stress

The authors of the above paper have issued several corrections, most notably a correction to the survival chart, figure 3.
Here are the corrected data: